Infrared Thermography and Physiological Variables as Methods for Recognizing Fear in Domestic Cats (Felis catus) Using Three Pharmacological Models: Cannabidiol, Gabapentin, and Synthetic Facial Pheromones
Authors:
- Fabiola Torres-BernalFabiola Torres-Bernal
- Julio Martínez-BurnesJMJulio Martínez-Burnes
- Ismael Hernández-AvalosIsmael Hernández-Avalos
- Adriana Olmos-HernándezAOAdriana Olmos-Hernández
- Adriana Domínguez-OiivaAdriana Domínguez-Oiiva
- Brenda Reyes-SoteloBRBrenda Reyes-Sotelo
- Cynthia González-LópezCGCynthia González-López
- Diana Villanueva-PereyraDVDiana Villanueva-Pereyra
- Daniel Mota-RojasDaniel Mota-Rojas
Open Access
- 27 May 2025
- journal article
- research article
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (6) , 523
Abstract
This study aimed to assess changes in the surface temperature and physiological parameters of cats exposed to a fear model involving negative dog–cat interactions, receiving three pharmacological options: a single dose of cannabidiol, gabapentin, or synthetic facial pheromones. The surface temperature of the upper and lower limbs, facial, dorsal, and appendicular thermal windows was assessed through infrared thermography. Additionally, heart rate, respiratory rate, and rectal temperature were recorded. Eighty male and female domestic cats were included in the study and randomly divided into four groups: CONTROL (placebo, 2 mL/cat orally), CBD (cannabidiol, 2 mg/kg orally), GABA (gabapentin, 100 mg/cat orally), and SFP (synthetic facial pheromone, two sprays/carrier). All cats underwent six experimental phases: Tbasal−, T1stfear, T1strecovery, Tbasal+, T2ndfear, and T2ndrecovery. Drug administration was carried out at the end of T1strecovery; the time between drug administration and Tbasal+ differed according to each drug’s nature. Statistical differences were obtained between experimental groups and times in the average surface temperature of thermal windows and cardiorespiratory parameters. In particular, the CBD, GABA, and SFP groups exhibited differences during T2ndfear, in contrast to the control and T1stfear groups. In conclusion, the results suggest a pharmacological effect of CBD, GABA, and SFP on cats’ physiological alterations in response to fear.Keywords
This publication has 95 references indexed in Scilit:
- Reducing fear, anxiety, and stress in veterinary clinics2024
- A comparative study between integrative practices and preappointement gabapentin on serum cortisol in catsVeterinary Research Communications, 2024
- Human–animal relationship influences husbandry practices, animal welfare and productivity in pig farmingAnimal, 2021
- Cannabidiol: pharmacology and therapeutic targetsPsychopharmacology, 2020
- The association between infrared thermal imagery of core eye temperature, personality, age and housing in catsApplied Animal Behaviour Science, 2017
- Cannabidiol as a Potential Treatment for Anxiety DisordersNeurotherapeutics, 2015
- Fear induced by the blockade of GABAA-ergic transmission in the hypothalamus of the cat: behavioral and neurochemical studyBehavioural Brain Research, 1995
- Activity of cat locus coeruleus noradrenergic neurons during the defense reactionBrain Research, 1990
- Distribution and function of peripheral α-adrenoceptors in the cardiovascular systemPharmacology Biochemistry and Behavior, 1985
- 5-HT concentration in cat's brainBrain Research, 1979